Does ENTRECTINIB Cause Pulmonary embolism? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Pulmonary embolism have been filed in association with ENTRECTINIB (Rozlytrek). This represents 0.9% of all adverse event reports for ENTRECTINIB.
13
Reports of Pulmonary embolism with ENTRECTINIB
0.9%
of all ENTRECTINIB reports
2
Deaths
10
Hospitalizations
How Dangerous Is Pulmonary embolism From ENTRECTINIB?
Of the 13 reports, 2 (15.4%) resulted in death, 10 (76.9%) required hospitalization.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for ENTRECTINIB.
What Other Side Effects Does ENTRECTINIB Cause?
Dizziness (143)
Off label use (137)
Death (126)
Disease progression (105)
Taste disorder (68)
No adverse event (65)
Constipation (60)
Fatigue (60)
Drug ineffective (58)
Blood creatinine increased (57)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which ENTRECTINIB Alternatives Have Lower Pulmonary embolism Risk?
ENTRECTINIB vs ENZALUTAMIDE
ENTRECTINIB vs EPCORITAMAB
ENTRECTINIB vs EPCORITAMAB-BYSP
ENTRECTINIB vs EPERISONE
ENTRECTINIB vs EPHEDRINE